, ,
Presentations this author is a contributor to:
Abiraterone acetate (AA) in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer (mCRPC): results of interim analysis (IA) of COU-AA-302, a randomized phase 3 study (#156)
10:15 AM
Paul de Souza
COSA Best of the Best Orals: Clinical Sciences
Cabazitaxel for patients with metastatic castration-resistant prostate cancer (mCRPC): Interim results from the Australian early access program [NCT01254279] (#866)
3:00 PM
Phillip Parente
COSA Posters: Education and Supportive Care